$ACUR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACURA PHARMACEUTICALS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACURA PHARMACEUTICALS, INC. Get notifications about new insider transactions in ACURA PHARMACEUTICALS, INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | ACUR | ACURA PHARMACEUTIC ... | Schutte John | 10% Owner | Buy | C | 0.16 | 42,984,375 | 6,877,500 | 42,984,375 | 0 to 43 M |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Option Exercise | M | 0.15 | 20,000 | 3,020 | 0 | |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Payment of Exercise | F | 0.40 | 7,550 | 3,020 | 474,042 | 481.6 K to 474 K (-1.57 %) |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Buy | M | 0.15 | 20,000 | 3,020 | 481,592 | 461.6 K to 481.6 K (+4.33 %) |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | M | 0.15 | 40,000 | 6,040 | 0 | |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Payment of Exercise | F | 0.40 | 15,100 | 6,040 | 416,097 | 431.2 K to 416.1 K (-3.50 %) |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Buy | M | 0.15 | 40,000 | 6,040 | 431,197 | 391.2 K to 431.2 K (+10.23 %) |
| Jan 12 2021 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | M | 0.00 | 54,790 | 0 | 0 | |
| Jan 12 2021 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Buy | M | 0.00 | 54,790 | 0 | 264,315 | 209.5 K to 264.3 K (+26.15 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | M | 0.00 | 54,790 | 0 | 0 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Buy | M | 0.00 | 54,790 | 0 | 312,171 | 257.4 K to 312.2 K (+21.29 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | M | 0.00 | 54,790 | 0 | 0 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Buy | M | 0.00 | 54,790 | 0 | 658,716 | 603.9 K to 658.7 K (+9.07 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | M | 0.00 | 54,790 | 0 | 0 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Buy | M | 0.00 | 54,790 | 0 | 392,657 | 337.9 K to 392.7 K (+16.22 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Treasurer & Con ... | Option Exercise | M | 0.01 | 20,000 | 200 | 49,333 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Treasurer & Con ... | Option Exercise | M | 0.01 | 4,667 | 47 | 64,666 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Treasurer & Con ... | Payment of Exercise | F | 0.21 | 10,686 | 2,244 | 341,138 | 351.8 K to 341.1 K (-3.04 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Treasurer & Con ... | Buy | M | 0.00 | 24,667 | 0 | 351,824 | 327.2 K to 351.8 K (+7.54 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | Jones Robert B | President & CEO | Option Exercise | M | 0.01 | 50,000 | 500 | 113,666 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | Jones Robert B | President & CEO | Option Exercise | M | 0.01 | 13,667 | 137 | 163,666 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | Jones Robert B | President & CEO | Buy | M | 0.00 | 63,667 | 0 | 489,889 | 426.2 K to 489.9 K (+14.94 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Option Exercise | M | 0.01 | 20,000 | 200 | 44,666 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Option Exercise | M | 0.01 | 4,667 | 47 | 64,666 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Payment of Exercise | F | 0.21 | 7,402 | 1,554 | 461,592 | 469 K to 461.6 K (-1.58 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Buy | M | 0.00 | 24,667 | 0 | 468,994 | 444.3 K to 469 K (+5.55 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | M | 0.01 | 40,000 | 400 | 89,332 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | M | 0.01 | 9,334 | 93 | 129,332 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Payment of Exercise | F | 0.21 | 19,514 | 4,098 | 391,197 | 410.7 K to 391.2 K (-4.75 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Buy | M | 0.00 | 49,334 | 0 | 410,711 | 361.4 K to 410.7 K (+13.65 %) |
| Jan 08 2020 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | A | 0.00 | 54,790 | 0 | 54,790 | |
| Jan 08 2020 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | M | 0.00 | 83,333 | 0 | 0 | |
| Jan 08 2020 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Buy | M | 0.00 | 83,333 | 0 | 209,525 | 126.2 K to 209.5 K (+66.04 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Option Exercise | M | 0.01 | 4,667 | 47 | 69,333 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Buy | M | 0.00 | 4,667 | 0 | 444,327 | 439.7 K to 444.3 K (+1.06 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | M | 0.01 | 9,334 | 93 | 138,666 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Payment of Exercise | F | 0.23 | 3,090 | 711 | 361,377 | 364.5 K to 361.4 K (-0.85 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Buy | M | 0.00 | 9,334 | 0 | 364,467 | 355.1 K to 364.5 K (+2.63 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Pharmaceutical S ... | Option Exercise | M | 0.01 | 9,334 | 93 | 120,666 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Pharmaceutical S ... | Buy | M | 0.00 | 9,334 | 0 | 325,334 | 316 K to 325.3 K (+2.95 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | A | 0.00 | 54,790 | 0 | 54,790 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | D | 0.00 | 33,333 | 0 | 0 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | M | 0.00 | 50,000 | 0 | 33,333 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Payment of Exercise | F | 0.23 | 3,624 | 834 | 257,381 | 261 K to 257.4 K (-1.39 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Buy | M | 0.00 | 50,000 | 0 | 261,005 | 211 K to 261 K (+23.70 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | A | 0.00 | 54,790 | 0 | 54,790 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | M | 0.00 | 83,333 | 0 | 0 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Buy | M | 0.00 | 83,333 | 0 | 337,867 | 254.5 K to 337.9 K (+32.74 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | A | 0.00 | 54,790 | 0 | 54,790 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | M | 0.00 | 83,333 | 0 | 0 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Buy | M | 0.00 | 83,333 | 0 | 603,926 | 520.6 K to 603.9 K (+16.01 %) |
| Jul 11 2019 | ACUR | ACURA PHARMACEUTIC ... | Schutte John | 10% Owner | Option Exercise | J | 0.01 | 10,000,000 | 100,000 | 10,000,000 | |
| Jul 11 2019 | ACUR | ACURA PHARMACEUTIC ... | Schutte John | 10% Owner | Option Exercise | J | 0.01 | 10,000,000 | 100,000 | 10,000,000 | |
| Jan 08 2019 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | A | 0.00 | 83,333 | 0 | 83,333 | |
| Jan 08 2019 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | M | 0.00 | 66,666 | 0 | 0 | |
| Jan 08 2019 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Buy | M | 0.00 | 66,666 | 0 | 126,192 | 59.5 K to 126.2 K (+111.99 %) |
| Jan 08 2019 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | A | 0.00 | 83,333 | 0 | 83,333 | |
| Jan 08 2019 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | M | 0.00 | 66,666 | 0 | 0 | |
| Jan 08 2019 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Buy | M | 0.00 | 66,666 | 0 | 520,593 | 453.9 K to 520.6 K (+14.69 %) |
| Jan 04 2019 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | A | 0.00 | 83,333 | 0 | 83,333 | |
| Jan 04 2019 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | M | 0.00 | 66,666 | 0 | 0 | |
| Jan 04 2019 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Buy | M | 0.00 | 66,666 | 0 | 254,534 | 187.9 K to 254.5 K (+35.49 %) |
| Jan 04 2019 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | A | 0.00 | 83,333 | 0 | 83,333 | |
| Jan 04 2019 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | M | 0.00 | 66,666 | 0 | 0 | |
| Jan 04 2019 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Buy | M | 0.00 | 66,666 | 0 | 211,005 | 144.3 K to 211 K (+46.19 %) |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | Jones Robert B | President & CEO | Option Exercise | A | 0.15 | 50,000 | 7,550 | 50,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | Jones Robert B | President & CEO | Option Exercise | A | 0.01 | 150,000 | 1,500 | 150,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Controller & Tr ... | Option Exercise | A | 0.15 | 20,000 | 3,020 | 20,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Controller & Tr ... | Option Exercise | A | 0.01 | 60,000 | 600 | 60,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | A | 0.15 | 40,000 | 6,040 | 40,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | A | 0.01 | 120,000 | 1,200 | 120,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Pharmaceutical S ... | Option Exercise | A | 0.15 | 34,000 | 5,134 | 34,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Pharmaceutical S ... | Option Exercise | A | 0.01 | 102,000 | 1,020 | 102,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.15 | 20,000 | 3,020 | 20,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.01 | 60,000 | 600 | 60,000 | |
| Jan 04 2018 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | A | 0.00 | 66,666 | 0 | 66,666 | |
| Jan 04 2018 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | D | 0.00 | 23,809 | 0 | 0 | |
| Jan 04 2018 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | M | 0.00 | 35,714 | 0 | 23,809 | |
| Jan 04 2018 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Buy | M | 0.00 | 35,714 | 0 | 59,526 | 23.8 K to 59.5 K (+149.98 %) |
| Jan 03 2018 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | A | 0.00 | 66,666 | 0 | 66,666 | |
| Jan 03 2018 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | M | 0.00 | 82,774 | 0 | 0 | |
| Jan 03 2018 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Buy | M | 0.00 | 82,774 | 0 | 144,339 | 61.6 K to 144.3 K (+134.45 %) |
| Jan 02 2018 | ACUR | ACURA PHARMACEUTIC ... | CLAUDIUS LLC | Sell | S | 0.10 | 2,195,734 | 219,573 | 0 | 2.2 M to 0 (-100.00 %) | |
| Dec 18 2017 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Buy | P | 0.10 | 50,000 | 5,000 | 61,565 | 11.6 K to 61.6 K (+432.34 %) |
| Dec 18 2017 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Buy | P | 0.10 | 100,000 | 10,000 | 128,345 | 28.3 K to 128.3 K (+352.80 %) |
| Dec 18 2017 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Buy | P | 0.10 | 400,000 | 40,000 | 439,660 | 39.7 K to 439.7 K (+1,008.57 %) |
| Dec 15 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Buy | P | 0.10 | 300,000 | 30,000 | 316,000 | 16 K to 316 K (+1,875.00 %) |
| Dec 15 2017 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Buy | P | 0.10 | 335,734 | 33,573 | 394,404 | 58.7 K to 394.4 K (+572.24 %) |
| Dec 15 2017 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Controller & Tr ... | Buy | P | 0.10 | 300,000 | 30,000 | 322,490 | 22.5 K to 322.5 K (+1,333.93 %) |
| Dec 15 2017 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Buy | P | 0.10 | 300,000 | 30,000 | 355,182 | 55.2 K to 355.2 K (+543.66 %) |
| Dec 15 2017 | ACUR | ACURA PHARMACEUTIC ... | Jones Robert B | President and CEO | Buy | P | 0.10 | 400,000 | 40,000 | 412,555 | 12.6 K to 412.6 K (+3,185.98 %) |
| Dec 11 2017 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 0.00 | 28,000 | 0 | 28,000 | |
| Dec 11 2017 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
| Dec 11 2017 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Controller & Tr ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
| Dec 11 2017 | ACUR | ACURA PHARMACEUTIC ... | Jones Robert B | President and CEO | Option Exercise | A | 0.00 | 41,000 | 0 | 41,000 | |
| Dec 11 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Option Exercise | A | 0.00 | 28,000 | 0 | 28,000 | |
| Aug 29 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Buy | P | 0.47 | 1,000 | 470 | 16,000 | 15 K to 16 K (+6.67 %) |
| Aug 29 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Buy | P | 0.47 | 1,000 | 470 | 15,000 | 14 K to 15 K (+7.14 %) |
| Aug 29 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Buy | P | 0.47 | 2,000 | 940 | 14,000 | 12 K to 14 K (+16.67 %) |
| Aug 29 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Buy | P | 0.45 | 2,000 | 909 | 12,000 | 10 K to 12 K (+20.00 %) |
| Aug 29 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Buy | P | 0.48 | 1,800 | 864 | 10,000 | 8.2 K to 10 K (+21.95 %) |
| Aug 29 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Buy | P | 0.48 | 1,000 | 480 | 8,200 | 7.2 K to 8.2 K (+13.89 %) |
| Aug 29 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Buy | P | 0.48 | 1,000 | 480 | 7,200 | 6.2 K to 7.2 K (+16.13 %) |
| Aug 29 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Buy | P | 0.48 | 1,000 | 480 | 6,200 | 5.2 K to 6.2 K (+19.23 %) |
| Aug 10 2017 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Option Exercise | A | 0.45 | 35,000 | 15,750 | 35,000 | |
| Aug 10 2017 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Controller & Tr ... | Option Exercise | A | 0.45 | 14,000 | 6,300 | 14,000 | |
| Aug 10 2017 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.45 | 14,000 | 6,300 | 14,000 | |
| Aug 10 2017 | ACUR | ACURA PHARMACEUTIC ... | Jones Robert B | President and CEO | Option Exercise | A | 0.45 | 47,000 | 21,150 | 47,000 | |
| Aug 10 2017 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 0.45 | 34,000 | 15,300 | 34,000 | |
| Feb 08 2017 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Controller & Tr ... | Option Exercise | M | 0.92 | 1,166 | 1,067 | 12,384 | |
| Feb 08 2017 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Controller & Tr ... | Payment of Exercise | F | 1.30 | 821 | 1,067 | 22,490 | 23.3 K to 22.5 K (-3.52 %) |
| Feb 08 2017 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Controller & Tr ... | Buy | M | 0.92 | 1,166 | 1,067 | 23,311 | 22.1 K to 23.3 K (+5.27 %) |
| Jan 05 2017 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | A | 0.00 | 59,523 | 0 | 59,523 | |
| Jan 05 2017 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | M | 0.00 | 22,026 | 0 | 0 | |
| Jan 05 2017 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Buy | M | 0.00 | 22,026 | 0 | 58,670 | 36.6 K to 58.7 K (+60.11 %) |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | A | 0.00 | 59,523 | 0 | 59,523 | |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | M | 0.00 | 13,216 | 0 | 0 | |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | D | 0.00 | 8,810 | 0 | 13,216 | |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Buy | M | 0.00 | 13,216 | 0 | 28,345 | 15.1 K to 28.3 K (+87.36 %) |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | A | 0.00 | 59,523 | 0 | 59,523 | |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | M | 0.00 | 13,216 | 0 | 0 | |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | D | 0.00 | 8,810 | 0 | 13,216 | |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Buy | M | 0.00 | 13,216 | 0 | 23,812 | 10.6 K to 23.8 K (+124.73 %) |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | A | 0.00 | 59,523 | 0 | 59,523 | |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | M | 0.00 | 735 | 0 | 0 | |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | D | 0.00 | 490 | 0 | 735 | |
| Jan 04 2017 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Buy | M | 0.00 | 735 | 0 | 11,565 | 10.8 K to 11.6 K (+6.79 %) |
| Dec 12 2016 | ACUR | ACURA PHARMACEUTIC ... | Brzeczko Albert W | VP Technical Affair ... | Option Exercise | A | 0.92 | 35,000 | 32,025 | 35,000 | |
| Dec 12 2016 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 0.92 | 34,000 | 31,110 | 34,000 | |
| Dec 12 2016 | ACUR | ACURA PHARMACEUTIC ... | Jones Robert B | President and CEO | Option Exercise | A | 0.92 | 47,000 | 43,005 | 47,000 | |
| Dec 12 2016 | ACUR | ACURA PHARMACEUTIC ... | Seiser Robert A | VP, Controller & Tr ... | Option Exercise | A | 0.92 | 14,000 | 12,810 | 14,000 | |
| Dec 12 2016 | ACUR | ACURA PHARMACEUTIC ... | Rivet J Bradley | VP Marketing | Option Exercise | A | 0.92 | 14,000 | 12,810 | 14,000 | |
| Dec 12 2016 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.92 | 14,000 | 12,810 | 14,000 | |
| Jan 06 2016 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | A | 0.00 | 22,026 | 0 | 22,026 | |
| Jan 06 2016 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | M | 0.00 | 6,185 | 0 | 0 | |
| Jan 06 2016 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Option Exercise | D | 0.00 | 4,124 | 0 | 6,185 | |
| Jan 06 2016 | ACUR | ACURA PHARMACEUTIC ... | THANGARAJ IMMANUEL | Director | Buy | M | 0.00 | 6,185 | 0 | 10,596 | 4.4 K to 10.6 K (+140.22 %) |
| Jan 06 2016 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | A | 0.00 | 22,026 | 0 | 22,026 | |
| Jan 06 2016 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Option Exercise | M | 0.00 | 10,309 | 0 | 0 | |
| Jan 06 2016 | ACUR | ACURA PHARMACEUTIC ... | WESSON BRUCE F | Director | Buy | M | 0.00 | 10,309 | 0 | 36,644 | 26.3 K to 36.6 K (+39.15 %) |
| Jan 05 2016 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | A | 0.00 | 22,026 | 0 | 22,026 | |
| Jan 05 2016 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | M | 0.00 | 8,247 | 0 | 0 | |
| Jan 05 2016 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Option Exercise | D | 0.00 | 2,062 | 0 | 8,247 | |
| Jan 05 2016 | ACUR | ACURA PHARMACEUTIC ... | SKELLY WILLIAM G | Director | Buy | M | 0.00 | 8,247 | 0 | 15,129 | 6.9 K to 15.1 K (+119.83 %) |
| Jan 05 2016 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | A | 0.00 | 22,026 | 0 | 24,476 | |
| Jan 05 2016 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | M | 0.00 | 8,074 | 0 | 2,450 | |
| Jan 05 2016 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Option Exercise | D | 0.00 | 3,460 | 0 | 10,524 | |
| Jan 05 2016 | ACUR | ACURA PHARMACEUTIC ... | ROSS GEORGE K | Director | Buy | M | 0.00 | 8,074 | 0 | 10,830 | 2.8 K to 10.8 K (+292.96 %) |
| Dec 14 2015 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 2.01 | 50,000 | 100,500 | 50,000 | |
| Dec 14 2015 | ACUR | ACURA PHARMACEUTIC ... | Rivet J Bradley | VP Marketing | Option Exercise | A | 2.01 | 20,000 | 40,200 | 20,000 |